Krefeld, Germany

Harold Pielartzik

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Corporation. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harold Pielartzik: Innovator in Sulfonated Aliphatic Compounds

Introduction

Harold Pielartzik is a notable inventor based in Krefeld, Germany. He has made significant contributions to the field of chemistry, particularly in the development of sulfonated aliphatic compounds. His innovative work has led to advancements that are applicable in various industries.

Latest Patents

Harold Pielartzik holds 1 patent for his invention titled "Sulfonated aliphatic compounds." This patent discloses a process for incorporating sulfonic acid groups into the structure of an aliphatic, non-polar, water-insoluble compound. The process involves dissolving the compound in an appropriate solvent and reacting it in the presence of a catalyst and oxygen with an aqueous sulfite solution. The sulfonation process renders the compound polar and water absorbent, making it suitable for a variety of applications.

Career Highlights

Harold Pielartzik is associated with Bayer Corporation, a leading global enterprise in the field of pharmaceuticals and life sciences. His work at Bayer has allowed him to explore innovative solutions and contribute to the company's research and development efforts.

Collaborations

Throughout his career, Harold has collaborated with esteemed colleagues such as Gundolf Jacobs and Bin Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Harold Pielartzik's contributions to the field of chemistry, particularly through his patent on sulfonated aliphatic compounds, highlight his role as an innovator. His work continues to influence various applications and showcases the importance of research and development in advancing technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…